The injection frequency is the same for both: once weekly, on the same day each week, at any time of day
It can also support muscle recovery so you can hit the gym more quickly after a brutal workout
It is expected to lead to expanded indications for semaglutide (potentially an indication for reduction of CV risk in obese patients)
Currently, once-weekly subcutaneous semaglutide 2.4 mg is approved for chronic weight management in adults with obesity, or overweight and with at least one weight-related comorbidity 17 , for reducing CV risk in adults with established cardiovascular disease (CVD) with obesity or overweight 18 , and in adolescents aged 12 years and older 19 , in conjunction with a reduced-calorie diet and increased physical activity plan
Yuan K, Xie K, Lan T, Xu L, Chen X, Li X